Title: Further Use of Protein Kinase N Beta. Number: 20040106569. Filed: Aug. 14, 2003. Lead Inventor: Anke Klippel-Giese, Atugen.
According to the patent application's abstract, the invention "is related to the use of protein kinase N beta or a fragment or derivative thereof as a downstream target of the PI-3 kinase pathway, preferably as a downstream drug target of the PI 3-kinase pathway."